MedElevator
Войти в исследования Plastic and reconstructive surgery · 2011
Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature.
Consensus StatementСтатьяКлинические рекомендацииОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bengtson Bradley, Brody Garry S, Brown Mitchell H, Glicksman Caroline, Hammond Dennis, Kaplan Hilton, Maxwell G Patrick, Oefelein Michael G, Reisman Neal R, Spear Scott L, Jewell Mark L, Late Periprosthetic Fluid Collection after Breast Implant Working Group
Аннотация
BACKGROUND: The goal of this consensus is to establish an algorithm for the management of patients who develop a late or delayed periprosthetic fluid collection. A work group of practicing plastic surgeons and device industry physicians met periodically by teleconference and discussed issues pertinent to the diagnosis and management of late periprosthetic fluid collections in patients with breast implants. Based on these meetings, treatment recommendations and a treatment algorithm were prepared in association with an editorial assistant.
METHOD: The work group participants discussed optimal care approaches developed in their private practices and from evidence in the literature.
RESULTS: The consensus algorithm and treatment and management recommendations represent the consensus of the group.
CONCLUSIONS: The group concluded that late periprosthetic fluid collection (arbitrarily defined as occurring ≥ 1 year after implant) is an infrequently reported occurrence (0.1 percent) after breast implant surgery and that, at a minimum, management should include clinically indicated ultrasound-guided aspiration of fluid, with appropriate cultures and cytologic testing. Further evaluation and additional treatment is recommended for recurrence of periprosthetic fluid collection after aspiration, or clinical suspicion of infection or neoplasia.
METHOD: The work group participants discussed optimal care approaches developed in their private practices and from evidence in the literature.
RESULTS: The consensus algorithm and treatment and management recommendations represent the consensus of the group.
CONCLUSIONS: The group concluded that late periprosthetic fluid collection (arbitrarily defined as occurring ≥ 1 year after implant) is an infrequently reported occurrence (0.1 percent) after breast implant surgery and that, at a minimum, management should include clinically indicated ultrasound-guided aspiration of fluid, with appropriate cultures and cytologic testing. Further evaluation and additional treatment is recommended for recurrence of periprosthetic fluid collection after aspiration, or clinical suspicion of infection or neoplasia.